TY - JOUR
T1 - Palliative Endoscopic Esophageal Stenting for Malignant Esophageal Tumour Complications
T2 - A Clinical Case and Single Centre Experience in Latvia
AU - Straume, Zane
AU - Proskurina, Anna
AU - Strode, Zanda
AU - Sekretarjovs, Jurijs
AU - Skuja, Vita
AU - Urķe, Anete
AU - Lapiņa, Anita
AU - Derovs, Aleksejs
PY - 2020/5/26
Y1 - 2020/5/26
N2 - Esophageal stenting is used in patients with malignant esophageal tumours to reduce dysphagia and inanition. The objective of this study was to analyse the main reasons for esophageal stenting in Rīga East Clinical University Hospital (RECUH) and their association with dysphagia and mortality. A cross-sectional study of all patients hospitalised in RECUH who received esophageal self-expanding metal stents (SEMS) from October 2013 to December 2015 was performed. A total of 29 patients, 24 (82.8%) male and 5 (17.2%) female, with mean age 63.7 ± 11.3 years, underwent the procedure. The most common indications for stenting were tumour-related stenosis (52.9%) and fistulae (17.6%). Mean time from establishing the diagnosis of esophageal cancer to stent placement was 338.6 days. Median survival after stenting was 4.8 months. A complex case of a patient requiring placement of three palliative stents illustrates the challenges of esophageal cancer care. Esophageal stent placement is an effective palliative method for treating tumour-related symptoms but carries risks of stent complications and fistula development over time. SEMS are being successfully used in cancer patient treatment in Latvia.
AB - Esophageal stenting is used in patients with malignant esophageal tumours to reduce dysphagia and inanition. The objective of this study was to analyse the main reasons for esophageal stenting in Rīga East Clinical University Hospital (RECUH) and their association with dysphagia and mortality. A cross-sectional study of all patients hospitalised in RECUH who received esophageal self-expanding metal stents (SEMS) from October 2013 to December 2015 was performed. A total of 29 patients, 24 (82.8%) male and 5 (17.2%) female, with mean age 63.7 ± 11.3 years, underwent the procedure. The most common indications for stenting were tumour-related stenosis (52.9%) and fistulae (17.6%). Mean time from establishing the diagnosis of esophageal cancer to stent placement was 338.6 days. Median survival after stenting was 4.8 months. A complex case of a patient requiring placement of three palliative stents illustrates the challenges of esophageal cancer care. Esophageal stent placement is an effective palliative method for treating tumour-related symptoms but carries risks of stent complications and fistula development over time. SEMS are being successfully used in cancer patient treatment in Latvia.
KW - palliative care
KW - gastrointestinal cancer
KW - dysphagia
KW - tracheoesophageal fistula
UR - https://www.mendeley.com/catalogue/44e912ad-d38b-33aa-a2b8-b5bac0271d2f/
UR - http://www.scopus.com/inward/record.url?scp=85110264258&partnerID=8YFLogxK
U2 - 10.2478/prolas-2020-0020
DO - 10.2478/prolas-2020-0020
M3 - Article
SN - 2255-890X
VL - 74
SP - 125
EP - 130
JO - Proceedings of the Latvian Academy of Sciences, Section B: Natural, Exact, and Applied Sciences
JF - Proceedings of the Latvian Academy of Sciences, Section B: Natural, Exact, and Applied Sciences
IS - 2
ER -
